Stability of Neutrophil to Lymphocyte Ratio in Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Relationship with Clinical Outcomes: A Retrospective Cohort Study
Minjie Jiang,Yulong Yang,Haoyan Wang
DOI: https://doi.org/10.2147/copd.s487063
2024-11-16
International Journal of COPD
Abstract:Minjie Jiang, 1, 2 Yulong Yang, 2 Haoyan Wang 1 1 Department of Respiratory and Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, 100032, People's Republic of China; 2 Department of Respiratory and Critical Care Medicine, Hebei Yanda Hospital, Langfang, Hebei, 065201, People's Republic of China Correspondence: Haoyan Wang, Department of Respiratory and Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, No. 95 Yong'an Road, Xicheng District, Beijing, 100032, People's Republic of China, Email Background: More studies have focused on the clinical value of the measurement of the neutrophil-to-lymphocyte ratio (NLR) in acute exacerbations of chronic obstructive pulmonary disease (AECOPD). This study aims to assess the stability of NLR in hospitalized AECOPD patients and its relationship with clinical prognosis. Methods: This retrospective observational study recruited patients hospitalized with AECOPD from January 2020 to December 2023. Using receiver operating characteristic curves, we determined the optimal NLR cutoff, categorizing NLR stability into four groups: persistent high (NLR ≥ 3.8), increased (NLR < 3.8 at admission but ≥ 3.8 at discharge), decreased (NLR ≥ 3.8 at admission but < 3.8 at discharge), and persistent low (NLR < 3.8). Adverse hospital outcomes included hospital mortality, transfer to the intensive care unit (ICU), invasive mechanical ventilation (IMV), and length of hospital stay (LOS) ≥ 14 days. The associations between NLR stability and these outcomes were analyzed using multivariable logistic regression and Cox hazard analysis. Results: Among 841 patients hospitalized for AECOPD, the mean age was 72.1± 9.5 years, with 644 males (76.6%) and 197 females (23.4%). The proportions and distribution for groups: persistent high, decreased, increased, and persistent low groups were 109 (12.9%), 175 (20.8%), 216 (25.7%), and 341 (40.5%), respectively. The persistent high group had the worst outcomes, including higher IMV use, ICU transfer, LOS > 14 days, and hospital cost, compared to the persistent low group. Compared to the persistent high group, the persistent low group (HR: 0.13; 95% CI: 0.10– 0.24) and the decreased group (HR: 0.40; 95% CI: 0.22– 0.73) are statistically significant for the risk of death, while the increased group (HR: 0.63; 95% CI: 0.37– 1.04) does not show a statistically significant difference. Conclusion: AECOPD patients who have persistent low NLR group face a low risk of adverse hospital outcomes and mortality after 6 months after discharge. The stability of NLR may serve as a novel biomarker for identifying AECOPD patients at increased risk of poor hospital outcomes. Keywords: neutrophil-to-lymphocyte ratio, acute exacerbations of chronic obstructive pulmonary disease, outcomes Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) closely correlates with rapid lung function decline, heightened rehospitalization rates, and increased disease-related mortality. 1 Annually, three million individuals succumb to chronic obstructive pulmonary disease (COPD), 2 with a staggering 90% of fatalities occurring in low- and middle-income nations, imposing substantial economic and healthcare burdens. 3 The etiology of AECOPD is multifaceted, encompassing infectious agents like viruses and bacteria, alongside non-infectious triggers such as smoking and air pollution;yet the precise underlying cellular and molecular mechanisms remain elusive. 4 This prompts the search for new, easily obtainable prognostic biomarkers to facilitate early identification of AECOPD patients at risk of adverse outcomes. Inflammation and immunity play crucial roles in the pathogenesis and progression of AECOPD. Neutrophils serve as the frontline defense against pathogens, while lymphocytes reflect the body's immune status and regulate inflammation. The ratio thereof comprehensively mirrors the body's immune-inflammatory equilibrium. 5–7 The neutrophil-lymphocyte ratio (NLR) has garnered widespread attention in recent years as a biomarker for predicting hospital outcomes and subsequent exacerbations in AECOPD patients. 8,9 Nevertheless, controversy shrouds the stability of NLR in AECOPD patients, with sole reliance on initial NLR at admission proving inadequate for accurately prognosticating clinical outcomes and prognosis. Moreover, investigations concerning the relationship between NLR stability during hospitalization for AECOPD and patient clinical outcomes remain conspicuously absent. Hence, this study aims to further delineate the distribution of NLR stability during hospitalization for AECOPD patients and -Abstract Truncated-
respiratory system